NCT06361277View on ClinicalTrials.gov

To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

November 3, 2023

Primary Completion Date

November 20, 2023

Study Completion Date

November 27, 2023

Conditions

Healthy

Interventions

DRUG

Reference Drug or Test Drug

Tablet, Oral, QD for 1 Day, Washout period is more than 7 days after administration

Trial Locations (1)

Unknown

Clinical Trial Center, Jeonbuk National University Hospital, Jeonju

Sponsors

Lead Sponsor

JW Pharmaceutical

All Listed Sponsors

lead

JW Pharmaceutical

INDUSTRY